|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.34 USD | +1.44% |
|
-0.82% | +0.38% |
| 06-26 | Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets | MT |
| 06-24 | Merck Wins European Commission Approval for KEYTRUDA Plus Padcev in Bladder Cancer | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +7.13% | +9.97% | +11.56% | +37.56% | +12.42% | +55.80% | +160.09% | +424.77% | +1,513.19% | 1,077B | |
| +3.99% | +11.50% | +10.10% | +5.91% | +23.05% | +67.09% | +55.96% | +55.08% | +118.50% | 613B | |
| +4.20% | +17.03% | +17.62% | +20.99% | +10.88% | +38.97% | +91.06% | +124.24% | +331.75% | 448B | |
| +0.99% | +4.85% | +1.33% | +7.30% | +2.16% | +28.17% | +23.89% | -2.76% | +39.19% | 332B | |
| +1.82% | +8.19% | +2.21% | +0.11% | +3.83% | +40.04% | +27.95% | +68.47% | +247.02% | 293B | |
| +0.22% | +6.75% | +5.60% | +5.99% | +15.22% | +31.30% | +42.34% | +49.16% | +67.59% | 286B | |
| +0.73% | +8.53% | +9.60% | +39.15% | -2.24% | -27.33% | -39.55% | +24.44% | +85.99% | 215B | |
| +1.56% | +6.14% | +6.63% | +2.74% | +9.48% | +29.30% | +60.97% | +47.66% | +147.84% | 193B | |
| +3.26% | +3.33% | -4.35% | -4.74% | +4.19% | +15.55% | +68.24% | +88.39% | +63.42% | 159B | |
| +2.62% | -3.65% | -7.33% | -10.17% | -2.45% | +0.41% | -33.31% | -37.69% | -28.14% | 138B | |
| +2.32% | +8.79% | +12.38% | +13.46% | +8.38% | +11.34% | +41.55% | +152.82% | +515.41% | 125B | |
| +3.85% | +6.52% | 0.00% | -1.74% | +6.64% | +24.10% | -11.17% | -13.81% | -18.20% | 117B | |
| -0.03% | +2.99% | +2.24% | -3.22% | +8.69% | +41.09% | +41.42% | +12.26% | +6.61% | 104B | |
| +1.78% | +1.25% | -2.68% | -8.44% | -9.25% | -9.00% | -23.31% | -14.93% | +6.60% | 103B | |
| -1.33% | -1.54% | -5.64% | -12.95% | -9.81% | -1.08% | +78.44% | +67.36% | +529.11% | 75.68B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| 0.00% | +24.21% | +23.29% | +22.84% | +26.99% | +74.24% | -6.49% | -9.25% | -45.96% | 52.66B | |
| +0.65% | +3.10% | -0.80% | -12.89% | +5.21% | +16.51% | +13.37% | +35.36% | +17.05% | 49.71B | |
| -2.74% | +0.52% | -3.38% | -11.80% | -18.30% | -6.31% | +5.92% | -28.49% | +224.99% | 47.27B | |
| Average | +1.63% | +5.87% | +4.36% | +5.00% | +5.28% | +23.90% | +33.19% | +57.95% | +212.33% | 236.47B | |
| Weighted average by Cap. | +3.34% | +7.81% | +7.44% | +14.39% | +9.51% | +36.80% | +67.20% | +141.27% | +479.10% |
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
- Sector Astellas Pharma Inc.
Select your edition
All financial news and data tailored to specific country editions
